[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# Akero Therapeutics, Inc. Common Stock (AKRO)

Novo Nordisk has officially completed its acquisition of Akero Therapeutics for $XXX billion, with potential for an additional $X per share CVR upon US regulatory approval of Akero's lead drug.

### About Akero Therapeutics, Inc. Common Stock
Akero Therapeutics, Inc. Common Stock (AKRO) is a biotechnology company focused on developing treatments for serious metabolic diseases.  
Akero Therapeutics, Inc. Common Stock uses the ticker $AKRO for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Akero Therapeutics, Inc. Common Stock (AKRO) mentions hit XX which is XXX% higher than it's daily average.
- Akero Therapeutics, Inc. Common Stock (AKRO) engagements hit 17K which is 2650% higher than it's daily average.
- Akero Therapeutics, Inc. Common Stock (AKRO) creators hit XX which is XXX% higher than it's daily average.
- Akero Therapeutics, Inc. Common Stock (AKRO) social dominance hit XXXXXX which is 2082% higher than it's daily average.
- Akero Therapeutics, Inc. Common Stock (AKRO) market dominance near a 52-week low at XXXXXXX.
- Akero Therapeutics, Inc. Common Stock (AKRO) trading volume is up XXXXXX% from the previous week.
- Akero Therapeutics, Inc. Common Stock (AKRO) social dominance is up 7450% from the previous X months.
- Akero Therapeutics, Inc. Common Stock (AKRO) Galaxy Score™ is up XXXXX% from the previous month.
- Akero Therapeutics, Inc. Common Stock (AKRO) creators is up XXXXXX% from the previous week.
- Akero Therapeutics, Inc. Common Stock (AKRO) engagements is up 5688.82% from the previous X months.
- Akero Therapeutics, Inc. Common Stock (AKRO) mentions is up XXXXXX% from the previous week.
- Akero Therapeutics, Inc. Common Stock (AKRO) posts created is up XXXXXX% from the previous year.

### Price: $XXXXX
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:akro-akero-therapeutics-inc/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/akro-akero-therapeutics-inc/time-series/close.tsv)  
The price of AKRO is likely influenced by the acquisition news from Novo Nordisk, with upfront payments and potential additional shares signaling strong investor confidence and a positive outlook for the company's lead drug.  

24-Hour: XXXX%
7-Day: XXXX%
30-Day: XXXX%

1-Year High: $XXXXX on 2025-02-05  
1-Year Low: $XXXXX on 2025-01-14  
  
  
### AltRank: XXX
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:akro-akero-therapeutics-inc/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/akro-akero-therapeutics-inc/time-series/alt_rank.tsv)  
Akero Therapeutics, Inc. Common Stock (AKRO) is currently AltRank #776 based on combined combined social and market metrics
Daily Average: XXXXX  
X Week: XXX -XXX  
X Month: XXX -XXX  
X Months: XXX +125  
X Year: XXX -XXXXX  
1-Year High: XXXXX on 2025-09-17  
1-Year Low: XX on 2025-10-09  
  
  
### Galaxy Score: XXXXX
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:akro-akero-therapeutics-inc/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/akro-akero-therapeutics-inc/time-series/galaxy_score.tsv)  
Current Value: XXXXX  
Daily Average: XX  
X Week: XX +21  
X Month: XX +38  
X Months: XX +6  
X Year: XX +27  
1-Year High: XXX on 2025-05-29  
1-Year Low: XX on 2025-11-06  
  
  
### Engagements: XXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:akro-akero-therapeutics-inc/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/akro-akero-therapeutics-inc/time-series/interactions.tsv)  
Current Value: XXXXX  
Daily Average: XXX  
X Week: XXXXXX +3,323%  
X Month: XXXXXX +145%  
X Months: XXXXXXX +5,689%  
X Year: XXXXXXX +2,655%  
1-Year High: XXXXXX on 2025-11-13  
1-Year Low: X on 2024-12-15  

Engagements by network (24h):
Reddit: XXX
TikTok: XX
X: XXXXX
YouTube: XX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:akro-akero-therapeutics-inc/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/akro-akero-therapeutics-inc/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: X  
X Week: XX +244%  
X Month: XX -XXXX%  
X Months: XXX +392%  
X Year: XXX +1,231%  
1-Year High: XX on 2025-10-20  
1-Year Low: X on 2024-12-12  

Mentions by network (24h):
Reddit: XX
TikTok: X
X: XXX
YouTube: X

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:akro-akero-therapeutics-inc/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/akro-akero-therapeutics-inc/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Akero Therapeutics, Inc. Common Stock (AKRO) in the last XX hours which is up XX% from XX in the previous XX hours
Daily Average: X  
X Week: XX +222%  
X Month: XX -XX%  
X Months: XXX +856%  
X Year: XXX +1,938%  
1-Year High: XX on 2025-10-20  
1-Year Low: X on 2024-12-12  

The most influential creators that mention Akero Therapeutics, Inc. Common Stock in the last XX hours

| Creator                            | Rank | Followers | Posts | Engagements |
| -------                            | ---- | --------- | ----- | ----------- |
| [@Chaka8](/creator/twitter/Chaka8) | X    | XXXXX     | X     | X           |

[View More](/list/creators/akro-akero-therapeutics-inc/100)
  
  
### Sentiment: XXX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:akro-akero-therapeutics-inc/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/akro-akero-therapeutics-inc/time-series/sentiment.tsv)  
Current Value: XXX%  
Daily Average: XX%  
X Month: XXX% no change  
X Months: XXX% +33%  
1-Year High: XXX% on 2025-02-23  
1-Year Low: XX% on 2025-02-09  

Most Supportive Themes:
- Increased Social Engagement: (70%) Akero Therapeutics (AKRO) has seen a significant surge in social media activity, with engagements up by 3763.5% over the last X months and posts created up by XX% in the past week.
- Positive Social Dominance Trend: (20%) Social dominance for AKRO has increased by XXXXX% from the previous week, indicating a growing share of online conversation.
- Rising Galaxy Score: (10%) The Galaxy Score™ for AKRO has risen by XXXXX% from the previous week, suggesting improved overall social and market metrics.
  
Most Critical Themes:
  
  
  
### Social Dominance: XXXXXX%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:akro-akero-therapeutics-inc/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/akro-akero-therapeutics-inc/time-series/social_dominance.tsv)  
Current Value: XXXXXX%  
Daily Average: XXXXXXXX%  
X Week: XXXXX% +0.01%  
X Month: XXXXX% +0.015%  
X Months: XXXXX% +0.015%  
X Year: XXXXX% +0.015%  
1-Year High: XXXXX% on 2025-12-11  
1-Year Low: XXXXXX% on 2025-06-17  
  
  
### Market Dominance: XXXXXXX%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:akro-akero-therapeutics-inc/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/akro-akero-therapeutics-inc/time-series/market_dominance.tsv)  
Current Value: XXXXXXX%  
Daily Average: X%  
1-Year High: XXXXX% on 2025-11-23  
1-Year Low: XXXXXX% on 2025-12-10  
  
  
### Market Cap: $XXXXXXXXXXXXX
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:akro-akero-therapeutics-inc/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/akro-akero-therapeutics-inc/time-series/market_cap.tsv)  
Current Value: $XXXXXXXXXXXXX  
Daily Average: $XXXXXXXXXXXXX  
X Week: $XXXXXXXXXXXXX +$0.69%  
X Month: $XXXXXXXXXXXXX +$0.95%  
X Months: $XXXXXXXXXXXXX +$1.50%  
X Year: $XXXXXXXXXXXXX +$110%  
1-Year High: $XXXXXXXXXXXXX on 2025-12-03  
1-Year Low: $XXXXXXXXXXXXX on 2025-01-14  

### Top Akero Therapeutics, Inc. Common Stock Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"🚨 Novo closed Akero - my thoughts. The News Novo Nordisk ( $NVO) completed the purchase of Akero Therapeutics paying $XX per share in cash plus a non-transferable $X CVR tied to US approval of efruxifermin for compensated cirrhosis due to MASH. Akero is now a wholly owned subsidiary and its stock will be delisted from Nasdaq. The CVR pays only if full US approval is secured by June XX 2031. Efruxifermin is an FGF21 analogue now in Phase X across the SYNCHRONY program. The Phase 2b HARMONY and SYMMETRY trials reported meaningful fibrosis improvements including regression signals even in F4"  
[X Link](https://x.com/HatedMoats/status/1998836211834859634) [@HatedMoats](/creator/x/HatedMoats) 2025-12-10T19:24Z 8974 followers, 4193 engagements


"🚀 NOVO NORDISK SHARES SOAR My favourite healthcare stock is experiencing sharp gain today (+3.58%) most likely driven by the official completion of the strategic acquisition of Akero Therapeutics. NVO strengthens its position in obesity treatment and MASH/NASH liver diseases. Long-term vision pays off. #NovoNordisk #Stocks"  
[X Link](https://x.com/JL_BYWealth/status/1998832547044696402) [@JL_BYWealth](/creator/x/JL_BYWealth) 2025-12-10T19:09Z XXX followers, XXX engagements


"$NVO $AKRO @novonordisk (NVO) has officially acquired Akero Therapeutics (AKRO) for $XX per share plus a $X CVR totaling up to $XXX billion. With EFX now under Novos control and a massive MASH market ahead analysts say this deal could redefine the global obesity and metabolic disease landscape"  
[X Link](https://x.com/BioTechHealthX/status/1998789076225503689) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-12-10T16:17Z XXX followers, XX engagements


"@novonordisk finalizes its USD 4.7B acquisition of Akero Therapeutics strengthening its position in MASH therapies as EFX advances through Phase X. A USD 6/share CVR awaits US approval. #PharmaNews #Biotech #MetabolicDisease"  
[X Link](https://x.com/pharma_eu/status/1998688770934321313) [@pharma_eu](/creator/x/pharma_eu) 2025-12-10T09:38Z XX followers, XX engagements